Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.66+0.06 (+3.75%)
Close on Nov 17, 2026Market cap $4.22MP/E –Yield –
Alaunos Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alaunos Therapeutics's enterprise value was $3.88M on Nov 11, 2026, against $5.43M a year earlier. Over the last 5 years it ranged from $818.57K to $496.27M, with a median of $6.42M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.88M | -25.2% |
| 2025 | Dec 31, 2025 | $5.19M | +279.3% |
| 2024 | Dec 31, 2024 | $1.37M | -72.1% |
| 2023 | Dec 29, 2023 | $4.90M | -95.6% |
| 2022 | Dec 30, 2022 | $111.24M | -33.8% |
| 2021 | Dec 31, 2021 | $168.07M | -58.4% |
| 2020 | Dec 31, 2020 | $404.20M | -47.2% |
| 2019 | Dec 31, 2019 | $766.00M | +227.2% |
| 2018 | Dec 31, 2018 | $234.12M | -53.5% |
| 2017 | Dec 29, 2017 | $503.29M | -17.5% |
| 2016 | Dec 30, 2016 | $610.05M | -34.0% |
| 2015 | Dec 31, 2015 | $923.84M | +94.7% |
| 2014 | Dec 31, 2014 | $474.49M | +39.7% |
| 2013 | Dec 31, 2013 | $339.55M | +43.9% |
| 2012 | Dec 31, 2012 | $235.88M | +28.9% |
| 2011 | Dec 30, 2011 | $182.94M | +14.5% |
| 2010 | Dec 31, 2010 | $159.81M | – |
See a number that looks wrong?